ArticleBlood advances2026
Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM.
Manali Kamdar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it